Skip to main content
. 2017 Mar 1;28(5):624–633. doi: 10.1091/mbc.E16-09-0648

FIGURE 1:

FIGURE 1:

Interaction of KIF17 with the IFT46–IFT56 dimer demonstrated by the VIP assay. (A) Interaction of KIF17 with the IFT-B core subcomplex. Lysates were prepared from HEK293T cells coexpressing EGFP-KIF17 and all IFT-B subunits, all core subunits, or all peripheral subunits fused to mChe/tRFP and processed for the VIP assay using GST-tagged anti-GFP Nb as described in Materials and Methods. (B) A subtractive VIP assay was performed to determine the IFT-B core subunits involved in its interaction with KIF17. Lysates prepared from HEK293T cells coexpressing EGFP-KIF17 and all but one (as indicated) of the core subunits fused to mChe/tRFP were processed for the VIP assay. (C, D) Confirmation of the involvement of the IFT46–IFT56 dimer in the KIF17–IFT-B interaction. Lysates prepared from HEK293T cells coexpressing EGFP-KIF17 and mChe-tagged IFT46 (lane 1), IFT52 (lane 2), IFT56 (lane 3), IFT46 + IFT52 (lane 4), IFT46 + IFT56 (lane 5), or IFT46 + IFT52 + IFT56 (lane 6) were processed for the VIP assay (C) or immunoblotting analysis (D) as described in Materials and Methods. (E) Schematic representation of the interaction of KIF17 with the IFT46–IFT56 dimer in the IFT-B complex.